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Abstract
A response to Jorge Esteves, Carolina Maurente da Rosa, Caroline Kaercher Kramer, Luiz Eduardo Osowski, Stéfano
Milano and Luís Henrique Canani: Absence of diabetic retinopathy in a patient who has had diabetes mellitus for
69 years, and inadequate glycemic control: case presentation. Diabetology & Metabolic syndrome 2009, 1:13.
Response
We read with interest the case described by Jorge
Esteves et al. It is a well-documented case of a 73-year-
old woman who had type 1 diabetes mellitus for the
past 69 years, with no evidence of diabetic retinopathy
(DR), despite poor glycemic control and several risk fac-
tors for DR including the long duration of the disease,
early age at diagnosis of type 1 diabetes mellitus and
presence of hypertension and cardiovascular disease.
The patient’s case was regularly followed in the
Department of Ophthalmology for the past 20 years.
Recently, there were many reports of spontaneous
regression of DR [1-3]. It could be possible that the
patient also developed DR in the initial stages or during
the course of the disease which later regressed sponta-
neously. On visits for ophthalmic evaluation, the retinal
examination might have been normal with no signs of
spontaneously regressed DR.
There are certain documented ocular and systemic
factors which are known to protect a diabetic patient
against the development of DR. These include high
myopia, raised intraocular pressure and moderate caro-
tid stenosis. The patient’s intraocular pressure was
always within normal range but there was no mention
of her refractive status. If she was a high myope, this
could have contributed to protection from DR. Also,
since she was known to have significant macroangiopa-
thy manifested by peripheral vasculopathy and cardio-
vascular disease (myocardial infarction), a carotid
doppler examination could be planned at her next
follow-up to rule out carotid insufficiency as a factor
providing her protection against development of DR.
The authors have also drawn attention to the exis-
tence of locally protective genetic factors. They have
referred to some studies on the genetics of DR in which
the genes of aldose reductase, RAGE, VEGF, ACE, NOS,
ICAM-1 and PPAR-d have been considered candidates
for DR. We have also identified genetic factors impli-
cated in the predisposition to DR or protection against
the development of DR [4-9]. RAGE, the receptor for
AGE, gains its importance in the disease mechanism of
DR through its interaction with AGE and subsequent
initiation of a series of intracellular changes. While ana-
lysis of polymorphisms in RAGE gene yielded no asso-
ciation with retinopathy in other studies, we reported a
protective association of Gly82Ser for development of
DR [5]. Later we found that the Z-2 allele of aldose
reductase gene was associated with risk for DR among
the Indian population, comparable to worldwide results
[6]. We also investigated a promoter microsatellite (GT)
ni nt h eTNF gene for association with retinopathy in a
self reported diabetic cohort. We found a low risk allele
((GT)9) and a high risk allele ((GT)13) for DR in this
gene [7]. Later we worked on a pentanucleotide repeat
poly-morphism (CCTTT)n in inducible NOS (iNOS)
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alleles ((CCTTT)13&17) and a high risk allele ((CCTTT)
13) for DR [8]. Recently, we also reported that the 27 bp
intron4 VNTR of eNOS gene was not associated with DR
in a population-based South Indian cohort, much to the
contradiction of worldwide reports [9].
Although there seems to be some biologically plausi-
ble mechanisms which offer some protection against
DR, a study of a larger cohort of such subjects with dia-
betes, including systemic, local and genetic factors will
provide better evidences.
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